Boston Scientific CorporationBSXNYSE
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
7.85
↑ 55% above average
Average (9y)
5.05
Historical baseline
Range
High:7.85
Low:3.27
CAGR
+10.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 7.85 | +33.0% |
| 2023 | 5.90 | +13.0% |
| 2022 | 5.22 | +2.7% |
| 2021 | 5.08 | -1.1% |
| 2020 | 5.14 | -12.3% |
| 2019 | 5.86 | +18.0% |
| 2018 | 4.97 | +32.4% |
| 2017 | 3.75 | +7.2% |
| 2016 | 3.50 | +6.9% |
| 2015 | 3.27 | - |